191 related articles for article (PubMed ID: 31067032)
1. Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in Vitro.
Zhang Y; Xiong X; Huai Y; Dey A; Hossen MN; Roy RV; Elechalawar CK; Rao G; Bhattacharya R; Mukherjee P
Bioconjug Chem; 2019 Jun; 30(6):1724-1733. PubMed ID: 31067032
[TBL] [Abstract][Full Text] [Related]
2. Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells.
Kalishwaralal K; Sheikpranbabu S; BarathManiKanth S; Haribalaganesh R; Ramkumarpandian S; Gurunathan S
Angiogenesis; 2011 Mar; 14(1):29-45. PubMed ID: 21061058
[TBL] [Abstract][Full Text] [Related]
3. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticles induce nanostructural reorganization of VEGFR2 to repress angiogenesis.
Pan Y; Ding H; Qin L; Zhao X; Cai J; Du B
J Biomed Nanotechnol; 2013 Oct; 9(10):1746-56. PubMed ID: 24015504
[TBL] [Abstract][Full Text] [Related]
5. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling.
Balaji Ragunathrao VA; Anwar M; Akhter MZ; Chavez A; Mao Y; Natarajan V; Lakshmikanthan S; Chrzanowska-Wodnicka M; Dudek AZ; Claesson-Welsh L; Kitajewski JK; Wary KK; Malik AB; Mehta D
Cell Rep; 2019 Dec; 29(11):3472-3487.e4. PubMed ID: 31825830
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression.
Tang D; Gao J; Wang S; Ye N; Chong Y; Huang Y; Wang J; Li B; Yin W; Wang D
Tumour Biol; 2016 Feb; 37(2):1889-99. PubMed ID: 26323258
[TBL] [Abstract][Full Text] [Related]
8. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
9. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2.
Huang W; Xing Y; Zhu L; Zhuo J; Cai M
Exp Cell Res; 2021 Sep; 406(1):112633. PubMed ID: 34089726
[TBL] [Abstract][Full Text] [Related]
11. Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling.
Awasthi N; Schwarz MA; Verma V; Cappiello C; Schwarz RE
Lab Invest; 2009 Jan; 89(1):38-46. PubMed ID: 19002109
[TBL] [Abstract][Full Text] [Related]
12. Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.
Chiodelli P; Rezzola S; Urbinati C; Federici Signori F; Monti E; Ronca R; Presta M; Rusnati M
Oncogene; 2017 Nov; 36(47):6531-6541. PubMed ID: 28783175
[TBL] [Abstract][Full Text] [Related]
13. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer.
Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J
Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938
[TBL] [Abstract][Full Text] [Related]
14. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.
Lorenzon E; Colladel R; Andreuzzi E; Marastoni S; Todaro F; Schiappacassi M; Ligresti G; Colombatti A; Mongiat M
Oncogene; 2012 Jun; 31(26):3136-47. PubMed ID: 22020326
[TBL] [Abstract][Full Text] [Related]
15. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
[TBL] [Abstract][Full Text] [Related]
16. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
17. VEGF/Flk1 Mechanism is Involved in Roxarsone Promotion of Rat Endothelial Cell Growth and B16F10 Xenograft Tumor Angiogenesis.
Chen S; Xu J; Wei Q; Zhao Z; Chen X; Cui H; Zhang Y
Sci Rep; 2019 Nov; 9(1):17417. PubMed ID: 31758020
[TBL] [Abstract][Full Text] [Related]
18. OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling.
Song F; Chen Q; Rao W; Zhang R; Wang Y; Ge H; Wei Q
EBioMedicine; 2019 Mar; 41():156-166. PubMed ID: 30833190
[TBL] [Abstract][Full Text] [Related]
19. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
20. Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis.
Kabir AU; Lee TJ; Pan H; Berry JC; Krchma K; Wu J; Liu F; Kang HK; Hinman K; Yang L; Hamilton S; Zhou Q; Veis DJ; Mecham RP; Wickline SA; Miller MJ; Choi K
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
